Henrik Lindman

No ORCID on file · 1 paper in corpus
observational 2022
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2022.100470

BACKGROUND: Evidence on a possible association between newer hormonal contraceptives (HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen-only methods. METHODS: In this nationwide prospective cohort study…